H2020-EDIDP-CBRN-MCM-2020: Capabilities for CBRN risk assessment, detection, early warning and surveillance

The objective of this topic is to develop medical counter-measures (MedCM) for EU military forces to face current and emerging CBRN threats (mainly of biological and chemical nature).  The proposals must cover the design, prototyping and testing of one or several MedCMs, not excluding upstream or downstream activities.  Compared with the development of a standard medicine these activities must be understood as:- design: preclinical, in vitro studies;- prototyping: preclinical, in vivo studies;- testing: clinical, phase I studies.